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Abstract 
 
We aim to provide insight into the cause-specific mortality of older adults with ID, with and without Down 
syndrome (DS), and compare this to the general population. Immediate and primary cause of death were 
collected through medical files of 1050 older adults with ID, five years after the start of the Healthy Ageing 
and Intellectual Disabilities (HA-ID) study. During the follow-up period, 207 (19.7%) participants died, of 
whom 54 (26.1%) had DS.  Respiratory failure was the most common immediate cause of death (43.4%), 
followed by dehydration/malnutrition (20.8%), and cardiovascular diseases (9.4%). In adults with DS this 
was respiratory disease (73.3%), infectious and bacterial diseases (4.4%), and diseases of the digestive 
system (4.4%). Diseases of the respiratory system also formed the largest group of primary causes of 
death (32.1%; 80.4% was due to pneumonia), followed by neoplasms (17.6%), and diseases of the 
circulatory system (8.2%). In adults with DS the main primary cause was also respiratory diseases 
(51.1%), followed by dementia (22.2%). 
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Introduction 
 
During the last decades, life expectancy of people with intellectual disabilities (ID) has increased 
as a result of improved healthcare (Patja, Molsa, & Iivanainen, 2001). The mean mortality age for in-clinic 
people with ID has increased from 19 years in the 1930s (Carter & Jancar, 1983) to the late 50s - mid-60s 
in the late 1990s (Janicki, Dalton, Henderson, & Davidson, 1999). In 2013, a mean age at death of 64 
years was found in adults with mild to severe ID, with a decrease in the median age at death with 
increasing severity of ID (Heslop et al., 2014). The life expectancy of people with Down syndrome (DS) 
has increased as well, however their life expectancy is lower than that observed in the population of ID as 
a whole (Coppus, 2013).  
Although life expectancy of people with ID has increased, it still remains lower than that of the 
general population. This difference may be explained by the high prevalence of neurological disorders, 
congenital disorders and other chronic comorbidity in people with ID (Patja et al., 2001). These “ID-
specific conditions” are likely to contribute to the high prevalence of cardiovascular risk factors, 
depression, sleep disorders, and dysphagia (Bastiaanse, Kamp, Evenhuis, & Echteld, submitted; de 
Winter, Bastiaanse, Hilgenkamp, Evenhuis, & Echteld, 2012; Hermans, Beekman, & Evenhuis, 2013; van 
de Wouw, Evenhuis, & Echteld, 2013) in later life, which could be causes of premature death. Besides the 
lower life expectancy, the higher prevalence of these health conditions could also cause the distribution of 
causes of death in older adults with ID to be different than in the general population.  
One of the few studies that evaluated cause-specific mortality (Tyrer & McGrother, 2009) 
investigated adults with moderate to profound ID aged 20 years and over (n= 2995), and found a 
relatively high mortality caused by congenital abnormalities, diseases of the nervous system, mental 
disorder, and pneumonia. However, no distinction was made for different age groups or older adults 
specifically. Another study regarding cause-specific mortality in people with ID aged between 2 and 97 
years, found cardiovascular diseases, respiratory diseases, and neoplasms to be the three most common 
causes of death in both men and women with ID aged 40 years and over (Patja et al., 2001). In the 
general population the three most common causes of death were cardiovascular diseases, neoplasms, 
and external causes (for men) or respiratory diseases (for women). Thus in the study of Patja et al. (2001) 
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the cause-specific mortality differed significantly from the general population, with reduced mortality from 
cardiovascular diseases, neoplasms, and external causes, and increased mortality from respiratory 
diseases in adults with ID (Patja et al., 2001).  
So far, no studies have been performed regarding the cause-specific mortality of specifically the 
ageing (≥ 50 years) population with ID. Hardly any knowledge about mortality patterns in adults with ID 
past middle age is available, while the prolonged life expectancy creates a growing population of older 
adults with ID (Patja, Iivanainen, Vesala, Oksanen, & Ruoppila, 2000). Furthermore, previous studies 
have been performed several years ago and healthcare and therapies have improved since. Hence, there 
could have been changes in the cause-specific mortality.  
Therefore, the aim of this study is to provide more insight into the cause-specific mortality of older 
adults with ID aged 50 years and over. Cause-specific mortality will be assessed for the group as a 
whole, and for participants with and without DS separately. The secondary aim is to compare the cause-
specific mortality of this group to the cause-specific mortality in the general older population. 
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Methods 
 
Study design and participants 
This study was part of the Healthy Ageing and Intellectual Disability (HA-ID) study, a prospective cohort 
study performed in the Netherlands. In the HA-ID study, the health status of older adults with ID (≥ 50 
years) was investigated within three themes: 1) physical activity and fitness, 2) nutrition and nutrional 
state, and 3) mood and anxiety. Extensive measurements were taken for each theme, such as an 
extensive physical fitness assessment, physical activity measurements with pedometers, physical 
examination, swallowing observations, laboratory assessment, depression and anxiety screening, 
questionnaires regarding daily functioning and falls, in addition to obtaining information from medical files.  
Participants were recruited through three participating care organizations in the Netherlands. All 
clients aged 50 years and over receiving care from one of the participating organizations, ranging from 
residence with complete care to only ambulatory support without residence, were eligible to participate, 
without any other exclusion criteria. At the start of the study, in 2008, the care organizations provided care 
and support for 2322 clients aged 50 years and over, which were all invited to participate. Clients who 
were capable to decide themselves if they wanted to participate provided informed consent themselves, 
for clients who were not capable to do so the legal representative provided informed consent.  Eventually 
1050 clients participated in the HA-ID study. This was a near-representative sample of older adults with 
ID receiving formal care in the Netherlands, with an underrepresentation of 80 to 84 year-olds, and a 
slight overrepresentation of women. A more detailed description of the study design, recruitment, and 
representativeness of the sample has been published elsewhere (Hilgenkamp et al., 2011).  
The extensive baseline data collection on the three themes took place between November 2008 
and July 2010. All data were stored at and accessible from the server of the Erasmus MC, which has high 
standards regarding back-ups, safety, and privacy. After a 5-year follow-up period, mortality data were 
collected up to March 2015. The follow-up period ranges from 5 to 6.3 years, because we collected the 
follow-up data 5 years after the last baseline data collection, and the baseline data collection was 
performed over a period of one year and eight months. The study protocol was approved by the Medical 
Ethics Committee of the Erasmus MC, University Medical Center Rotterdam (MEC 2008-234 and MEC 
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2011-309) and the ethics committees of the participating care organizations. The study adheres to the 
guidelines of the Declaration of Helsinki. 
 
Procedures 
In March 2015, the client administration departments of the three participating care organizations 
were contacted to identify which of the participants were deceased and which of the participants were 
deregistered at the care organizations. Only the medical files of deceased participants who had an ID-
physician as their primary physician were available, and therefore used to collect information on deaths. 
An ID-physician is a specialized physician who has received a 3-year postgraduate university training 
combining learning and working in the field of care for people with ID. In the Netherlands, this is a 
recognized medical specialization. Medical files of the deceased participants who received primary care 
from a general practitioner were not available at the care organizations.  
Manner and cause of death (as explained below) were collected from the medical files by a 
medical student. If there were doubts about how to code and categorize a cause of death, this was 
discussed with a local panel of two ID-physicians until consensus was reached. The circumstances of the 
death and any contributing factors, were reviewed and discussed in this panel in order to determine the 
cause of death.  
For comparing the causes of death to the general population, cause-specific mortality data of the 
general 50+ population were obtained online from Statline, Statistics Netherlands (Centraal Bureau voor 
de Statistiek, 2014). 
 
Measurements 
Personal characteristics 
Information on age and sex were collected from the administrative systems. Level of ID was 
retrieved from psychologists’ and behavioral therapists’ files and was classified as borderline (intelligence 
quotient (IQ) = 70-80), mild (IQ = 55-70), moderate (IQ = 35-55), severe (I IQ = 25-35) or profound (IQ 
<25). The presence of DS, multimorbidity (presence of four or more chronic conditions (Hermans & 
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Evenhuis, 2014) and polypharmacy (use of five or more chronic medication) were collected from the 
medical files.  
 
Mortality data 
Manner of death 
The manner of death was either natural or non-natural. Natural death was defined as death solely 
caused by spontaneous disease.  A non-natural death was defined as every death directly or indirectly 
caused by an accident, violence, suicide, misconduct or intent by another person or any other external 
cause (Cohen, 2004). When a person was found dead, and death was completely unexpected and of 
unknown cause, the manner of dead was noted as unclear. 
 
Causes of death 
Both the immediate and primary causes of death were written down. The immediate cause of 
death was defined as the disease, injury or complication of which the patient died, and is the ultimate 
consequence of the underlying cause of death (Patja et al., 2001). The primary cause of death was 
defined as the disease or injury which initiated the train of morbid events leading directly to death, and is 
also called the underlying cause of death (World Health Organization, 2015b). For example, when a 
patient had colon carcinoma with hepatic metastases resulting in fatal liver failure, the immediate cause of 
death is liver failure, while the primary cause of death is colon cancer.  
This information was collected into a standardized form. Causes were coded according to the 10th 
revision of the International Statistical Classification of Diseases and related health problems (ICD-10), a 
coded list made by the World Health Organization (WHO) (World Health Organization, 2015a). When the 
cause of death was unclear, which was the case in people who had died and/or been found dead 
unexpectedly, the cause of death was noted as unknown.  
 
Statistical analysis 
To provide insights into the differences between the deceased and deregistered participants, 
because we could not assess if they had deceased and with what cause, we used t-tests for continuous 
MORTALITY IN OLDER PEOPLE WITH ID 
 
9 
 
variables, and Chi-square tests for dichotomous variables. Differences between deceased and survived 
participants, and participants whose medical file was available and whose medical file was not available 
were also assessed with independent sample t-tests for continuous variables, and Chi-square tests for 
dichotomous variables. Causes of death were categorized based on the main categories in the ICD-10. 
The frequencies of causes of death according to these main categories were ranked using percentages, 
for the total group and for participants with and without DS separately. Primary causes of death were 
compared against those of the general population, for the total group and per 5-year age category. 
Analyses were performed using the Statistical Package for Social Sciences version 21.0 (IBM 
Corporation, New York). A p value <0.05 was indicative for statistical significance.  
 
Results 
 
Characteristics of the study population 
The baseline characteristics of the total study sample, the deceased, and the deregistered 
participants are described in Table 1. At baseline, the mean age of the total study population (n = 1050) 
was 61.6 ± 8.0 years (range 50-93), and 51% was male.  
During the follow-up period (4.7 ± 1.4 years, 0 - 6.3 years), 207 (19.7%) participants died, and 56 
(5.3%) were deregistered during the follow-up period. Of the 149 participants with DS, 54 (36.2%) died 
during the follow-up period, which is 26.1% of the total group of participants that died during the follow-up 
period. The mean age at baseline for the deceased was 65.4 ± 9.5 years, and 59.7 ± 6.2 years for the 
deregistered group. Deregistered people were significantly younger (t = -5.3, p < 0.001), more often 
female (χ² = 4.9, p = 0.026), had less often multimorbidity (χ² = 47.5, p < 0.001), and less often 
polypharmacy (χ² = 31.9, p < 0.001) than deceased participants (Table 1).  When comparing deceased 
participants to those who survived, deceased participants were significantly older (t = 6.5, p < 0.001), 
more likely to have DS (χ² = 33.7, p < 0.001), multimorbidity (χ² = 47.5, p < 0.001), and polypharmacy (χ² 
= 31.9, p < 0.001). 
 Of the 207 participants who died within the follow-up period, 159 medical files were available to 
study the cause of death. Of these 159 participants, the mean age at time of death was 68.2 ± 9.8 years 
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(range 53-95). The participants whose files were available had more severe levels of ID (χ² = 6.59, p = 
0.037) and more multimorbidity (χ² = 25.2, p < 0.001) compared to the people whose file was not 
available. Characteristics of both subgroups are presented in Appendix A. 
 
[Table 1] 
 
Cause-specific mortality 
Manner of death 
From the 159 studied deaths, autopsy was performed in 3.8% (n=6) of the deceased participants. 
The manner of death was natural in 139 participants (87.4%), non-natural in five participants (3.1%) and 
unclear in 15 participants (9.4%). Of the non-natural deaths, four deaths were due to complications after a 
hip fracture caused by a fall, and one due to suffocation after choking on food. The 15 participants of 
whom the manner of death was unclear, had died suddenly and unexpected, with no clear cause of 
death. 
 
Immediate cause of death 
The immediate causes of death are presented in Table 2. For the total group, the largest group of 
immediate cause of death was respiratory failure (43.4%). Causes of respiratory failure were pneumonia, 
heart failure, lung cancer or neurological disease. The second largest group was dehydration/malnutrition 
(20.8%), either caused by the inability or unwillingness to eat or drink. The third largest group was 
cardiovascular diseases (9.4%), mostly acute myocardial infarction or arrhythmias. Of the group infectious 
and bacterial diseases, the main cause was sepsis (83.3%). With regard to diseases of the digestive 
system the main cause was liver failure, and for diseases of the urinary system the main cause was 
kidney failure. In 15.8% of the participants the immediate cause of death was unknown. 
 For older adults with DS, respiratory failure also formed the largest group of immediate cause of 
death (73.3%), followed by infectious and bacterial diseases (4.4%), and diseases of the digestive system 
(4.4%). For the group of older adults with ID by other causes than DS the largest group of immediate 
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cause of death was also respiratory failure (31.6%), followed by dehydration/malnutrition (28.1%), and 
cardiovascular diseases (12.3%) (Table 2).  
 
Primary cause of death 
The primary causes of death are presented in Table 3. Respiratory diseases formed the largest 
group of primary cause of death (32.1%). In 80.4% (n = 41) this was due to pneumonia, 17.6% (n =9) 
suffered from chronic obstructive pulmonary diseases, and one person had an acute upper respiratory 
infection. Neoplasms (17.6%) formed the second largest group. Out of all neoplasms, 50% (n =14) were 
digestive, 14.3% (n = 4) were urogenital, and 7.1% (n = 2) respiratory. Circulatory diseases formed 8.2% 
of causes of death. In 12.6% of the participants, the primary cause of death was unknown.   
 For older adults with DS, respiratory diseases also formed the largest group of primary cause of 
death (51.1%), followed by dementia (22.2%). For the group of older adults with ID by other causes than 
DS, again respiratory diseases formed the largest group of primary causes of death (24.6%), followed by 
neoplasms (21.9%), and diseases of the circulatory system (11.4%) (Table 3). 
 
[Table 2] 
 
[Table 3] 
 
Causes of death in the general population 
In the general 50+ population, the three largest groups of primary causes of death are neoplasms 
(31%), circulatory diseases (28%), and respiratory diseases (9%) (Centraal Bureau voor de Statistiek, 
2014). An overview of causes of death in the general population compared to our study population is 
presented in Figure 1. Appendix B shows the distribution of primary causes of death per 5-year age 
category for older adults with ID and the general population. 
 
[Figure 1] 
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Discussion 
In this study, the cause-specific mortality of 1050 older adults with ID was investigated. During the 5-year 
follow-up period, 19.7% of participants died. Of the participants with DS, 36.2% died during the follow-up 
period, which is 26.1% of the total group of participants that died during the follow-up period. Our findings 
show that older adults with ID are most likely to die from respiratory diseases, followed by neoplasms and 
circulatory diseases as a primary cause of death, with respiratory failure as the most common immediate 
cause of death, followed by dehydration/malnutrition, and cardiovascular diseases. In the general 
population, comparatively more deaths from neoplasms were found as a primary cause, followed by 
circulatory diseases and respiratory diseases respectively.  
Our findings on cause-specific mortality differ to some extent from findings of earlier studies. We 
found a greater proportion of deaths from respiratory diseases as the primary cause of death (32.1%) 
compared to Heslop et al. (2014), who found 15% of the deaths caused by respiratory diseases (Heslop 
et al., 2014). Our study population being older and having more severe levels of ID may explain this 
difference. Increasing age and severity of ID is linked with more neurological damage – resulting in 
abnormalities in swallow function and cough reflex - and medication use (Chadwick & Jolliffe, 2009). 
These factors, along with increasing age, are shown to be significant factors associated with dysphagia, 
thereby increasing the risk of respiratory tract infections (Marik & Kaplan, 2003; Park et al., 2013). 
 Many people died from respiratory diseases, especially pneumonias, which is a major concern. 
Dysphagia, leading to aspiration, is an important etiologic factor that could lead to pneumonia (Marik & 
Kaplan, 2003). Earlier findings in our study cohort showed that 77.4% of participants had dysphagia, of 
which 51.7% had moderate to severe dysphagia (Bastiaanse et al., submitted). In 89.5% of the people 
with dysphagia this diagnosis had not been registered in medical files (Bastiaanse et al., submitted). In 
adults with ID, risks associated with having dysphagia include aspiration, choking and asphyxiation, poor 
nutritional status, and dehydration (Chadwick & Jolliffe, 2009). These can have many negative health 
consequences, such as respiratory infections, asphyxia, and death (Chadwick & Jolliffe, 2009). Creating 
awareness of dysphagia among direct caregivers, and proactive screening by regular swallowing risk 
assessments is necessary to detect dysphagia. When diagnosed, an individual feeding plan and possible 
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treatments should be considered for each client, to prevent respiratory tract infections and life-threatening 
situations. 
 Furthermore, we found less deaths from circulatory diseases compared to earlier studies in adults 
with ID (Heslop et al., 2014; Patja et al., 2001; Tyrer & McGrother, 2009). This may be explained by the 
great proportion of unknown causes of death we found in our study. It has been shown that the majority 
(80%) of sudden unexpected deaths in the general population are caused by cardiovascular problems (de 
la Grandmaison, 2006; Naneix, Perier, Beganton, Jouven, & Lorin de la Grandmaison, 2015); hence it 
may be that most sudden unexpected deaths in our cohort were related to cardiac dysfunction. Indeed, 
there are indications that myocardial infarctions are more often missed in people with ID than in the 
general population (de Winter, van den Berge, Schoufour, Oppewal, & Evenhuis, 2016; Jansen, 
Rozeboom, Penning, & Evenhuis, 2013). If we were to classify 80% of unknown deaths in the group of 
circulatory diseases, we would have percentages similar to the earlier studies.  
We found fewer deaths from neoplasms (17.6%) than in the general population (31%). This is 
partly caused by the relative low number of deaths from neoplasms found in older adults with DS (6.7%). 
This may be due to their lower life expectancy. For the group older adults with ID by other causes than 
DS, death from neoplasms were more prevalent (21.9%) but still lower than in the general population. 
Because older adults with ID often have multimorbidity (Hermans & Evenhuis, 2014), there is a lot of 
awareness and often a careful consideration regarding the burden of the diagnostic examination in 
relation to the possible health gains and gains in quality of life with treatment, which may result in some 
underdiagnoses of neoplasms.  
More than a quarter of the participants that died during our follow-up period had DS. This can be 
explained by the lower life expectancy of people with DS (Coppus, 2013). Of the 149 participants with DS, 
54 died during our follow-up period (36.2%). In an earlier study regarding mortality in adults with DS aged 
45 years and over, 21.8% of the participants died within a mean follow-up period of 4.5 years (Coppus et 
al., 2008). This percentage is lower than the percentage found in our study, which may be caused by our 
longer follow-up period and slightly older study sample. 
The main primary cause of death in older adults with DS was diseases of the respiratory system, 
similar to the older adults with ID by other causes than DS. Dementia was the second largest primary 
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cause of death in older adults with DS. Dementia becomes increasingly prevalent in people with DS in 
later life, and was found to be associated with survival (Coppus, 2013; Coppus et al., 2008). We did not 
find diseases of the circulatory system to be a primary cause of death in older adults with DS.  This is in 
line with Coppus et al. (2008), who did not find diseases of the circulatory system to be related to survival 
in people with DS. In previous studies within our cohort we also found that older adults with DS had a 
lower prevalence of cardiovascular risk factors (de Winter et al., 2012), and we found that cardiovascular 
risk factors were predictive for 3-year all-cause mortality in older adults with ID (de Winter et al., 2016). 
This lower prevalence of risk factors in people with DS may be due to a protective mechanism related to 
the genetic syndrome (Coppus et al., 2008).  
Another important finding of this study is the great proportion of deaths with an unknown primary 
(12.6%) or immediate (15.8%) cause. Autopsy was performed in 3.8% of the deceased participants.  This 
number is comparable to that found in a study regarding deaths in 17 Dutch general practices (3%) over a 
two year period, in which 841 deaths occurred (Oppewal & Meyboom-de Jong, 2004). With autopsy, the 
cause of death can be traced in around 90% of cases (Lundberg & Voigt, 1979; van Ingen & Meijer, 
1994), and it can be made clear whether or not death was amenable or non-natural, and should thus be 
further managed by a forensic team. Often, emotional issues, administrative, and financial barriers are the 
main reasons for physicians not to perform autopsy (Oppewal & Meyboom-de Jong, 2001). However, it 
might have added value to obtain the cause of death for the medical team and caregivers in order to 
improve their knowledge and future care for other patients, and for the family to learn about possible 
hereditary disorders and help in their mourning process. 
Strengths of this study are the fairly long follow-up time and the large study population. 
Nevertheless, our results need to be interpreted with caution. First, despite our nearly representative 
study sample of older adults with ID, there might have been selection bias when determining the cause-
specific mortality. Older adults with borderline or mild ID who do not use any form of formal care have not 
been included in this cohort (Hilgenkamp, et al., 2011). Additionally, we were only able to include the 
medical files of participants who received care from an ID-physician; these participants had more severe 
levels of ID and more often multimorbidity than those receiving care from a general practitioner, and a 
higher percentage was female (Appendix A). Therefore, these people may have different mortality rates 
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and possibly other causes of death than those receiving care from a general practitioner, and these 
results may not be representative for those receiving care from a general practitioner. This may also be a 
reason for the differences in results with other studies as discussed previously. Second, information on 
causes of death in medical files was sometimes limited. This was either because very little was written 
down, or physicians did not know the cause of death because no diagnostic examination had been 
performed. In order to collect information on causes of death, we read the full medical files of the 
deceased participants, and if the cause of death was not clear, this was discussed with  a panel of ID-
physicians. 
 
Implications of the study  
In the Netherlands, following a death of a client the treating physician fills out two forms, form A 
concerning the death certificate and form B regarding the cause of death. Form B is anonymously 
collected by the Statistics Netherlands (Centraal Bureau voor Statistiek) to collect data on causes of 
death. This form is not linked to the medical files, and the cause of death is thus not always also noted in 
the medical files. It is recommended that a copy of this form is added to the medical file, so the 
registration of the causes of death is improved. 
In order to reduce the most common cause of death, diseases of the respiratory system, a 
proactive attitude from caregivers towards screening, monitoring and treating dysphagia is needed. 
Chronic obstructive pulmonary diseases was also found as a cause of diseases of the respiratory system, 
which may be associated with the increasing number of adults with ID smoking tobacco nowadays, and 
the second hand smoking with the staff of the care organizations, which was often the case before this 
was forbidden by law. This may also be of influence on the high prevalence of respiratory diseases as a 
cause of death.  
Another important issue this study raised is the great number of sudden unexpected deaths with 
unknown cause. It is important to consider autopsy in sudden unexpected deaths, because this can 
improve the knowledge of the medical team and caregivers and improve future care.  
 
Conclusion 
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In conclusion, the cause-specific mortality in older adults with ID was investigated in this study. 
Diseases of the respiratory system were the main primary cause of death, with respiratory failure as the 
main immediate cause of death. Due to this great number of deaths from respiratory diseases, and a high 
prevalence of dysphagia in this population, further studies to explore the potential link between dysphagia 
and risks, including mortality, in older adults with ID is required. Additionally, it is important to have special 
attention for groups at risk for dysphagia by close monitoring and proactive care. The large number of 
deaths with unknown cause shows that autopsy should be considered more often, and the registration of 
cause of death should be improved, since this both may improve future care. Future research is required 
to acquire more knowledge regarding cause-specific mortality in older adults with borderline of mild ID 
who do not use any form of formal care. 
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Table 1. Baseline characteristics of the study population 
 Total, n = 1,050 
(100%) 
Deceased, n = 207 
(19.7%) 
Deregistered, n = 56 
(5.3%) 
Age a (m ± sd) 
 n (%) 
61.6 ± 8.0 65.4 ± 9.5 59.7 ± 6.2* 
     50-59 yr 493 (47.0%) 61 (29.5%) 29 (51.8%) 
     60-69 yr 370 (35.2%) 81 (39.1%) 23 (41.1%) 
     70-79 yr 162 (15.4%) 50 (24.2%) 4 (7.1%) 
     80+ yr 25 (2.4%) 15 (7.3%) 0 (0.0%) 
Sex, n (%)    
     Male 538 (51.2%) 116 (56.0%) 22 (39.3%)* 
     Female 512 (48.8%) 91 (44.0%) 34 (60.7%) 
Level of ID, n (%)    
     Borderline 31 (2.9%) 2 (1.0%) 3 (5.7%) 
     Mild 223 (21.2%) 37 (18.5%) 10 (18.9%) 
     Moderate 506 (48.2%) 102 (51.0%) 29 (54.7%) 
     Severe    172 (16.4%) 35 (17.5%) 7 (13.2%) 
     Profound 91 (8.7%) 24 (12.0%) 4 (7.5%) 
Down syndrome, n 
(%) 
   
     No 724 (69.0%) 122 (58.9%) 27 (48.2%) 
     Yes 149 (14.2%) 54 (26.1%)  13 (23.2%) 
     Unknown 177 (16.8%) 31 (15.0%) 16 (28.6%) 
Multimorbidity b, n 
(%) 
   
     No 557 (53.0%) 64 (30.9%) 37 (66.1%)* 
     Yes 490 (46.7%) 142 (68.6%) 18 (32.1%) 
     Unknown 3 (0.3%) 1 (0.5%) 1 (1.8%) 
Polypharmacy c, n (%)    
     No 557 (53.0%) 79 (38.2%)  32 (57.1%) 
     Yes 366 (34.9%) 110 (53.1%) 11 (19.6%) 
     Unknown 127 (12.1%) 18 (8.7%) 13 (23.2%) 
a Age at time of inclusion in study. 
b Defined as the presence of ≥ 4 chronic conditions. 
c Defined as the use of ≥ 5 chronic medication. 
* Indicating a significant difference between deregistered and deceased participants, p < 0.05. 
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Table 2. Immediate causes of death, n (%). 
Cause of death (category)  
Follow-up time, mean and 
range 
 
Total group (n = 159) 
4.7 ± 1.4,  
0 – 6.3 years 
DS (n = 45) 
4.6 ± 1.5,  
0 – 6.3 years 
ID no DS (n = 114) 
4.8 ± 1.3,  
0 – 6.3 years 
Respiratory failure  69 (43.4%) 33 (73.3%) 36 (31.6%) 
Dehydration / malnutrition 33 (20.8%) 1 (2.2%) 32 (28.1%) 
Unknown 25 (15.8%) 5 (11.1 %) 20 (17.5%) 
Cardiovascular diseases 15 (9.4%) 1 (2.2%) 14 (12.3%) 
Infectious and bacterial 
diseases 
6 (3.8%) 2 (4.4%) 4 (3.5%) 
Other 5 (3.1%) 1 (2.2%) 4 (3.5%) 
Diseases of the digestive 
system 
3 (1.9%) 2 (4.4%) 1 (0.9%) 
Diseases of the urinary system 3 (1.9%) - 3 (2.6%) 
ID = intellectual disability; DS = Down syndrome. 
 
  
Table 3. Primary causes of death. 
Total group (n = 159) 
n (%) 
Total group (n 
= 159) 
DS (n = 45) ID no DS (n = 114) 
Diseases of the respiratory 
system  
51 (32.1%) 23 (51.1%) 28 (24.6%) 
Neoplasms 28 (17.6%) 3 (6.7%) 25 (21.9%) 
Unknown 20 (12.6%) 3 (6.7%) 17 (14.9%) 
Diseases of the circulatory 
system 
13 (8.2%) - 13 (11.4%) 
Dementia 13 (8.2%) 10 (22.2%) 3 (2.6%) 
Diseases of the nervous system 11 (6.9%) 3 (6.7%) 8 (7.0%) 
Other 11 (6.9)% 2 (4.4%) 9 (7.9%) 
External cause 7 (4.4%) 1 (2.2%) 6 (5.3%) 
Diseases of the digestive system 5 (3.1%) - 5 (4.4%) 
ID = intellectual disability; DS = Down syndrome. 
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Appendix A. Characteristics of the deceased participants. 
 Deceased participants 
whose file was availablea 
(n=159) 
Deceased participants 
whose file was not available 
(n=48) 
Age (in years) at time of death, mean 
± SD 
68.2 ± 9.8 67.5 ± 8.2 
Sex   
Male, n (%) 81 (50.9%) * 35 (72.9%) * 
Female, n (%) 78 (49.1%) * 13 (27.1%) * 
Level of ID   
Mild, n (%) 26 (16.7%) * 13 (29.5%) * 
Moderate, n (%) 78 (50.0%) * 24 (54.5%) * 
Severe, n (%) 52 (33.3%) * 7 (15.9%) * 
Diagnosed with Down syndrome, n 
(%) 
45 (31.2%) 9 (28.1%) 
Presence of multimorbidity, n (%) 123 (77.8%) * 19 (39.6%) * 
Presence of polypharmacy, n (%) 91 (60.3%) 19 (50.0%) 
* Indicating a significant difference between the two groups, with p < 0.05. 
a Medical files of deceased participants who received medical care by a specialized ID-physician 
were available for the study. Medical files of participants who received care from a general 
practitioner were not available. 
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Appendix B.  Percentages of primary causes of death per 5-year age category for older adults with ID and the general population. 
Cause of death 
(category) 
50 – 54 yrs  
 
55 – 59 yrs  60 – 64 yrs 65 – 69 yrs 70 – 74 yrs 75 – 79 yrs 80 – 84 yrs 85– 90 yrs 90 – 95 yrs 95+ yrs 
 ID 
 
Gen 
 
ID  
 
Gen 
 
ID 
 
Gen 
 
ID 
 
Gen 
 
ID 
 
Gen  ID 
 
Gen 
 
ID 
 
Gen 
 
ID 
 
Gen 
 
ID  Gen 
 
ID 
 
Gen 
 
 
 
 
 
% n 
= 
2 
n 
= 
37
28
 
 n
= 
34
 
n 
= 
55
58
 
n 
= 
35
 
n 
= 
18
18
0 
n 
= 
23
 
n 
= 
11
83
9 
n 
= 
21
 
n 
= 
13
26
5 
n 
= 
16
 
n 
= 
17
58
2 
n 
= 
19
 
n 
= 
24
01
9 
n 
= 
3 
n 
= 
25
56
4 
n 
= 
5 
n 
= 
18
14
6 
n 
= 
1 
n 
= 
70
83
 
Diseases of the 
respiratory system  
100 3.3 26.5 4.7 51.4 6.0 30.4 6.7 23.8 8.6 12.5 9.4 26.3 10.3 - 9.9 40.0 10.4 100 10.9 
Neoplasms - 50.7 17.6 52.4 8.6 53.7 8.7 51.5 42.9 46.5 12.5 37.1 15.8 27.8 66.7 18.9 20.0 12.4 - 6.8 
Diseases of the 
circulatory system 
- 16.9 5.9 16.6 8.6 18.0 8.7 21.0 4.8 22.8 18.8 26.8 5.3 30.1 - 33.7 40.0 34.6 - 33.9 
Mental & 
behavioral disease 
(incl. dementia) 
- 1.9 17.6 2.2 11.4 1.7 4.3 1.9 - 2.8 12.5 5.2 - 8.1 - 11.5 - 14.0 - 15.1 
Diseases of the 
nervous system 
- 3.0 5.9 3.2 11.4 3.2 8.7 3.2 9.5 4.0 - 5.1 5.3 5.8 - 5.6 - 5.2 - 4.8 
Other - 11.4 8.7 10.8 - 10.0 8.6 9.9 4.8 10.2 6.2 10.7 15.9 11.6 33.3 13.5 - 15.6 - 21.3 
External cause - 9.3 2.9 6.6 2.9 3.8 4.3 2.5 4.8 2.3 6.2 2.8 10.6 3.0 - 3.8 - 4.6 - 4.5 
Diseases of the 
digestive system 
- 3.6 5.9 3.5 - 3.5 4.3 3.3 4.8 2.8 - 3.0 5.3 3.2 - 3.3 - 3.2 - 3.1 
ID = Intellectual disabilities; Gen = General population. 
